Publications

Export 196 results:
Sort by: [ Author (Desc)] Title Type Year
Filters: Author is Fox, Keith A A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y
Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, et al. Irbesartan in patients with atrial fibrillation. N Engl J Med. 2011;364(10):928-38. Abstract
W
Woudstra P, Grundeken MJ, van de Hoef TP, Wallentin L, Fox KA, de Winter RJ, et al. Prognostic relevance of PCI-related myocardial infarction. Nat Rev Cardiol. 2013;10(4):231-6. Abstract
Witherow FN, Dawson P, Ludlam CA, Fox KA, Newby DE. Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy. Journal of the American College of Cardiology. 2002;40:961-6. Abstract
West RM, Cattle BA, Bouyssie M, Squire I, de Belder M, Fox KA, et al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur Heart J. 2011;32(6):706-11. Abstract
West RM, Cattle BA, Bouyssie M, Squire I, de Belder M, Fox KA, et al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. European heart journal. 2010. Abstract
Weber M, Bhatt DL, Brennan DM, Hankey GJ, Steinhubl SR, Johnston CS, et al. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial. Heart. 2011;97(8):626-31. Abstract
Wauters E, Carruthers KF, Buysschaert I, Dunbar DR, Peuteman G, Belmans A, et al. Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study. Eur Heart J. 2012. Abstract
V
Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012. Abstract
T
Topol EJ, Bousser M-, Fox KA, Creager MA, Despres J-, Easton DJ, et al. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet. 2010;376(9740):517-23. Abstract
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551-67.
Taggart DP, Boyle R, de Belder MA, Fox KA. The 2010 ESC/EACTS guidelines on myocardial revascularisation. Heart (British Cardiac Society). 2010.
Taggart DP, Boyle R, de Belder MA, Fox KA. The 2010 ESC/EACTS guidelines on myocardial revascularisation. Heart. 2011;97(6):445-6.
S
Sutherland GR, Stewart MJ, Groundstroem KW, Moran CM, Fleming A, Guell-Peris FJ, et al. Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr. 1994;7(5):441-58. Abstract
Steg PG, FitzGerald G, Fox KA. Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough. Am J Med. 2009;122(2):107-8.
Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). The American journal of cardiology. 2002;90:358-63. Abstract
Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. European heart journal. 2011. Abstract
Steg PG, Iung B, Feldman LJ, Cokkinos D, Deckers J, Fox KA, et al. Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart (British Cardiac Society). 2002;88:20-4. Abstract
Steg G, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. Grupo de Trabajo para el manejo del infarto agudo de miocardio con elevación del segmento ST de la Sociedad Europea de Cardiología (ESC). Rev Esp Cardiol. 2013;66(1):53.e1-53.e46.
Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2011;32(15):1854-64. Abstract
Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J. 2009;30(3):321-9. Abstract
Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012;33(20):2569-619.
Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007;116:2793-801. Abstract
Spencer FA, Montalescot G, Fox KA, Goodman SG, Granger CB, Goldberg RJ, et al. Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J. 2010;31(11):1328-36. Abstract
Spencer FA, Santopinto JJ, Gore JM, Goldberg RJ, Fox KA, Moscucci M, et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). The American journal of cardiology. 2002;90:1056-61. Abstract
Sinnaeve PR, Steg GP, Fox KA, Van de Werf F, Montalescot G, Granger CB, et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med. 2009;169(4):402-9. Abstract